These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

907 related articles for article (PubMed ID: 23932846)

  • 1. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.
    Aroor AR; McKarns S; Demarco VG; Jia G; Sowers JR
    Metabolism; 2013 Nov; 62(11):1543-52. PubMed ID: 23932846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.
    Lee BC; Lee J
    Biochim Biophys Acta; 2014 Mar; 1842(3):446-62. PubMed ID: 23707515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Dysfunction in Obesity and Therapeutic Targets.
    Engin A
    Adv Exp Med Biol; 2024; 1460():489-538. PubMed ID: 39287863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.
    Aroor A; McKarns S; Nistala R; DeMarco V; Gardner M; Garcia-Touza M; Whaley-Connell A; Sowers JR
    Cardiorenal Med; 2013 Apr; 3(1):48-56. PubMed ID: 23946724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity.
    Han JM; Patterson SJ; Speck M; Ehses JA; Levings MK
    J Immunol; 2014 Jan; 192(2):623-9. PubMed ID: 24323581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases.
    Molaei A; Molaei E; Hayes AW; Karimi G
    Cell Cycle; 2023 Jul; 22(13):1654-1674. PubMed ID: 37365840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns.
    Chatterton DE; Nguyen DN; Bering SB; Sangild PT
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1730-47. PubMed ID: 23660296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.
    Lastra G; Sowers JR
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):49-57. PubMed ID: 25436732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function.
    Guebre-Egziabher F; Alix PM; Koppe L; Pelletier CC; Kalbacher E; Fouque D; Soulage CO
    Biochimie; 2013 Nov; 95(11):1971-9. PubMed ID: 23896376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
    Lee YS; Jun HS
    Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats.
    Liu HQ; Qiu Y; Mu Y; Zhang XJ; Liu L; Hou XH; Zhang L; Xu XN; Ji AL; Cao R; Yang RH; Wang F
    Nutr Res; 2013 Oct; 33(10):849-58. PubMed ID: 24074743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice.
    Cole BK; Keller SR; Wu R; Carter JD; Nadler JL; Nunemaker CS
    Hypertension; 2010 Mar; 55(3):715-21. PubMed ID: 20100990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salt, aldosterone, and insulin resistance: impact on the cardiovascular system.
    Lastra G; Dhuper S; Johnson MS; Sowers JR
    Nat Rev Cardiol; 2010 Oct; 7(10):577-84. PubMed ID: 20697411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of infiltrating immune cells in dysfunctional adipose tissue.
    Guzik TJ; Skiba DS; Touyz RM; Harrison DG
    Cardiovasc Res; 2017 Jul; 113(9):1009-1023. PubMed ID: 28838042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in the cardiorenal metabolic syndrome.
    Whaley-Connell A; Sowers JR
    Curr Hypertens Rep; 2012 Aug; 14(4):360-5. PubMed ID: 22581415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.